Occam Places Mary Kay Fenton as CFO at Semma
_410x315.jpg)
Semma Therapeutics is a cell therapy company founded by Doug Melton of Harvard University and financed by ARCH Venture, MPM, and F-Prime. The company was subsequently acquired by Vertex for approximately $1B in late 2019.
In May 2019, Occam placed Mary Kay Fenton as CFO, having years of experience working with fast-growing biotech companies, most recently as EVP and CFO of Achillion Pharmaceuticals. With Fenton in place, Semma was subsequently acquired by Vertex for $1B.
Occam Global is an international life science executive search and leadership advisory firm dedicated to building management teams for innovative companies in the biotech, techbio, life sciences, and venture capital sectors. Our firm’s unique strength lies in our seamless access to elite talent, proven expertise in aligning exceptional business and scientific leaders with optimal opportunities, and a steadfast dedication to creating meaningful industry impact, guided by elevated ethics and enlightened aggression. Trusted by entrepreneurs, investors, and corporations worldwide, Occam Global is recognized as the premier partner for executive search and recruitment in the life sciences. Our success is rooted in establishing trust, cultivating and valuing relationships, and committing to serve as forthright and good-humored partners in realizing extraordinary ambitions.